Ionis Pharmaceuticals (IONS) PT Raised to $69 at Citi
Tweet
Share
E-mailGet Alerts IONS Hot Sheet
Price: $61.33 --0%
Rating Summary:
17 Buy, 11 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 2 | Down: 7 | New: 15
Rating Summary:
17 Buy, 11 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 2 | Down: 7 | New: 15
Join SI Premium – FREE
Citi analyst David Lebowitz raised the price target on Ionis Pharmaceuticals (NASDAQ: IONS) to $69.00 (from $65.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Truist Securities Downgrades Covista (CVSA) to Hold
- Kotak Upgrades Adani Ports & Special Economic Zone (ADSEZ:IN) to Buy (1)
- Neurocrine Bio. (NBIX) PT Raised to $253 at Citi
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Citi, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
